The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guérin (BCG): Updated follow-up from KEYNOTE-057.
 
Ronald De Wit
Honoraria - Merck Sharp & Dohme; Sanofi
Consulting or Advisory Role - Bayer; Clovis Oncology; Janssen; Merck Sharp & Dohme; Roche/Genentech; Sanofi
Research Funding - Bayer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Lilly
 
Girish S. Kulkarni
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen; Theralase
Travel, Accommodations, Expenses - Bayer; Ferring
 
Edward M. Uchio
Research Funding - Ambry Genetics; Bayer; Clovis Oncology; Genentech; GenomeDx; Genomic Health; Janssen Oncology; Merck; Merit Medical Systems; Myovant Sciences; Myovant Sciences; Myriad Genetics; Pfizer
 
Laurence Eliot Miles Krieger
Honoraria - Ipsen; Janssen-Cilag; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi
Speakers' Bureau - Abbvie; Janssen-Cilag; Merck Sharp & Dohme; Roche
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Janssen-Cilag (Inst); Roche (Inst)
Expert Testimony - Astellas Pharma; Ipsen; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Ipsen; Novartis
 
Joost L. Boormans
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Merck Sharp & Dome; Roche
Research Funding - GenomeDx
 
Mathieu Roumiguié
Honoraria - Ferring; Ipsen; Janssen; Sanofi
Consulting or Advisory Role - Janssen
Speakers' Bureau - Ferring; Ipsen; Sanofi
Expert Testimony - Janssen
Travel, Accommodations, Expenses - Ferring; Ipsen; Roche; Sanofi
 
Eric A. Singer
Research Funding - Astellas Medivation
 
Dean F. Bajorin
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EMD Serono; Fidia Farmaceutici S. p. A.; Genentech; Lilly; Lilly; Merck; Novartis; Pfizer; Roche; Roche/Genentech; Urogen pharma
Research Funding - Amgen (Inst); Astellas Pharma; AstraZeneca; Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck; Roche/Genentech; Urogen pharma
 
Ashish M. Kamat
Honoraria - AstraZeneca (I); Tesaro (I)
Consulting or Advisory Role - Abbott Molecular; Arquer Diagnostics; Bristol-Myers Squibb; CG Oncology; Eisai; Ferring; Heat Biologics; Imagin Medical; Merck; Photocure; Theralase; US Biotest
Research Funding - Bristol-Myers Squibb; FKD Therapies; Heat Biologics; Merck; Photocure
Patents, Royalties, Other Intellectual Property - Patent: CyPRIT (Cytokine Predictors of Response to Intravesical Therapy) joint with UT MD Anderson Cancer Center
Other Relationship - International Bladder Cancer Group (IBCG)
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Biocept; Bristol-Myers Squibb; Clovis Oncology; Driver, Inc; EMD Serono; Foundation Medicine; Genentech; HERON; Janssen; Merck; Pfizer; QED Therapeutics; Seagen
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Ho Kyung Seo
No Relationships to Disclose
 
Hiroyuki Nishiyama
Speakers' Bureau - Chugai Pharma; Merck Sharp & Dome
Research Funding - Astellas Pharma; Ono Pharmaceutical; Takeda
 
Badrinath R. Konety
Consulting or Advisory Role - MDxHealth
Research Funding - FKD Therapies (Inst); Genomic Health (Inst); Photocure (Inst); Roche/Genentech (Inst)
 
Kijoeng Nam
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ekta Kapadia
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Tara L. Frenkl
Employment - Amicus Therapeutics (I); Merck
Leadership - VenatoRx (I)
Stock and Other Ownership Interests - Amicus Therapeutics (I); AstraZeneca; AstraZeneca (I); GlaxoSmithKline; GlaxoSmithKline (I); Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Amicus Therapeutics (I); Merck
 
Arjun Vasant Balar
Honoraria - AstraZeneca/MedImmune; Genentech/Roche; Merck
Consulting or Advisory Role - AstraZeneca/MedImmune; Cerulean Pharma; Genentech/Roche; Incyte; Merck; Pfizer/EMD Serono; Seattle Genetics/Astellas
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Merck (Inst); Seagen